港股異動丨李寧5連升,創3個月新高
李寧(2331.HK)盤中拉昇,一度漲4.42%,報17港元,爲連續第5日上漲,股價創3月28日以來新高。消息面上,港交所數據顯示,6月20日,執行董事兼執行主席李寧增持李寧(2331.HK)100萬股,每股作價15.4789港元,總金額約爲1547.89萬港元。增持後最新持股數目爲3.01億股,持股比例爲11.63%。非凡領越(0933.HK)此前公佈,於今年1月至6月19日,在市場增持李寧合共1809萬股,涉及金額2.75億港元,摺合平均價15.2港元。完成後,非凡領越共計持有李寧2.9億股,佔其總股本11.23%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.